Download
10.1186_s40463-022-00558-w.pdf 3,28MB
WeightNameValue
1000 Titel
  • Introduction and expression of PIK3CA E545K in a papillary thyroid cancer BRAF V600E cell line leads to a dedifferentiated aggressive phenotype
1000 Autor/in
  1. Pinto, Nicole |
  2. Ruicci, Kara M. |
  3. Khan, Mohammed Imran |
  4. Shaikh, Mushfiq Hassan |
  5. Zeng, Yu Fan Peter |
  6. Yoo, John |
  7. Fung, Kevin |
  8. MacNeil, S. Danielle |
  9. Mendez, Adrian |
  10. Mymryk, Joe S. |
  11. barrett, john |
  12. Boutros, Paul C. |
  13. Nichols, Anthony C. |
1000 Verlag
  • SAGE Publications
1000 Erscheinungsjahr 2022
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2022-01-01
1000 Erschienen in
1000 Quellenangabe
  • 51(1):7
1000 Copyrightjahr
  • 2022
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40463-022-00558-w |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862267/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:p>Anaplastic thyroid cancer (ATC) is a rare, aggressive form of undifferentiated thyroid cancer, which exhibits rapid progression and is almost universally fatal. At least a subset of ATC is thought to arise from pre-existing well-differentiated thyroid cancer, most frequently papillary thyroid cancer (PTC). While <jats:italic>PIK3CA</jats:italic> mutations are rare in PTC, they are common in ATC and tend to co-occur with <jats:italic>BRAF</jats:italic> mutations. This provided the rationale for our study to identify the potential role of <jats:italic>PIK3CA</jats:italic> mutations in the progression from well-differentiated to undifferentiated thyroid cancer. We introduced <jats:italic>PIK3CA</jats:italic><jats:sup>E545K</jats:sup> into the LAM1 PTC cell line, which carries a <jats:italic>BRAF</jats:italic><jats:sup>V600E</jats:sup> mutation. In culture, the engineered cell line (LAM1:<jats:italic>PIK3CA</jats:italic><jats:sup>E545K</jats:sup>) proliferated faster and demonstrated increased clonogenic potential relative to the parental line carrying an empty vector (LAM1<jats:sup>EV</jats:sup>). Both the LAM1<jats:sup>EV</jats:sup> and LAM1:<jats:italic>PIK3CA</jats:italic><jats:sup>E545K</jats:sup> edited lines were implanted into hind flanks of athymic nude mice for in vivo determination of disease progression. While tumour weights and volumes were not significantly higher in LAM1:<jats:italic>PIK3CA</jats:italic><jats:sup>E545K</jats:sup> mice, there was a decrease in expression of thyroid differentiation markers TTF-1, thyroglobulin, PAX8 and B-catenin, suggesting that introduction of <jats:italic>PIK3CA</jats:italic><jats:sup>E545K</jats:sup> led to dedifferentiation in vivo. Collectively, this study provides evidence of a role for <jats:italic>PIK3CA</jats:italic><jats:sup>E545K</jats:sup> in driving disease progression from a well-differentiated to an undifferentiated thyroid cancer; however, over-expression was not a determinant of an accelerated growth phenotype in ATC.</jats:p> <jats:p><jats:bold>Graphical Abstract</jats:bold></jats:p>
1000 Sacherschließung
lokal Cell Line, Tumor [MeSH]
lokal Mutation [MeSH]
lokal Disease progression
lokal Proto-Oncogene Proteins B-raf/genetics [MeSH]
lokal Humans [MeSH]
lokal Cell Line [MeSH]
lokal Anaplastic thyroid cancer
lokal Thyroid Neoplasms/genetics [MeSH]
lokal Animals [MeSH]
lokal Papillary thyroid cancer
lokal Mice, Nude [MeSH]
lokal Thyroid Neoplasms/pathology [MeSH]
lokal Mice [MeSH]
lokal Dedifferentiation
lokal Class I Phosphatidylinositol 3-Kinases/genetics [MeSH]
lokal Original Research Article
lokal Phenotype [MeSH]
lokal Thyroid Cancer, Papillary/genetics [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UGludG8sIE5pY29sZQ==|https://frl.publisso.de/adhoc/uri/UnVpY2NpLCBLYXJhIE0u|https://frl.publisso.de/adhoc/uri/S2hhbiwgTW9oYW1tZWQgSW1yYW4=|https://frl.publisso.de/adhoc/uri/U2hhaWtoLCBNdXNoZmlxIEhhc3Nhbg==|https://frl.publisso.de/adhoc/uri/WmVuZywgWXUgRmFuIFBldGVy|https://frl.publisso.de/adhoc/uri/WW9vLCBKb2hu|https://frl.publisso.de/adhoc/uri/RnVuZywgS2V2aW4=|https://frl.publisso.de/adhoc/uri/TWFjTmVpbCwgUy4gRGFuaWVsbGU=|https://frl.publisso.de/adhoc/uri/TWVuZGV6LCBBZHJpYW4=|https://frl.publisso.de/adhoc/uri/TXltcnlrLCBKb2UgUy4=|https://orcid.org/0000-0003-3708-3834|https://frl.publisso.de/adhoc/uri/Qm91dHJvcywgUGF1bCBDLg==|https://frl.publisso.de/adhoc/uri/TmljaG9scywgQW50aG9ueSBDLg==
1000 Hinweis
  • DeepGreen-ID: ff8d6aca23874558b1bb406ec30745d5 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Institute of Cancer Research |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Institute of Cancer Research |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6479818.rdf
1000 Erstellt am 2024-05-22T00:15:52.500+0200
1000 Erstellt von 322
1000 beschreibt frl:6479818
1000 Zuletzt bearbeitet 2024-05-22T14:42:36.673+0200
1000 Objekt bearb. Wed May 22 14:42:36 CEST 2024
1000 Vgl. frl:6479818
1000 Oai Id
  1. oai:frl.publisso.de:frl:6479818 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source